Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
MA

Mark Anthony Ashwell — 12 Patents

Pfizer: 7 patents #741 of 5,153Top 15%
APAmerimas Home Products: 3 patents #217 of 715Top 35%
NSNimbus Saturn: 2 patents #12 of 16Top 75%
Carlisle, MA: #74 of 364 inventorsTop 25%
Massachusetts: #10,639 of 88,656 inventorsTop 15%
Overall (All Time): #396,045 of 4,157,543Top 10%
12 Patents All Time
Mark Anthony Ashwell has been granted 12 US patents while listed as an inventor at Pfizer. The first was granted in 1999 and the most recent in March 2025. Mark Anthony Ashwell ranks #396,045 of 4,157,543 US inventors in our database (top 9.5%). Patent records list Mark Anthony Ashwell in Carlisle, MA, US.

Patents per Year

Patents granted per year, 1999 to 2025Bar chart with a peak of 4 patents in 2003.peak 41999: 1 patents19992001: 2 patents20012002: 1 patents20022003: 4 patents20032007: 1 patents20072008: 1 patents20082024: 1 patents20242025: 1 patents2025

Issued Patents All Time

Showing 1–12 of 12 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12252488 HPK1 antagonists and uses thereof Neelu Kaila, Ian Linney, Stuart Ward, Grant Wishart, Benjamin Paul Whittaker +3 more 2025-03-18
11926625 HPK1 antagonists and uses thereof Neelu Kaila, Ian Linney, Stuart Ward, Grant Wishart, Benjamin Paul Whittaker +3 more 2024-03-12
7378427 Processes for preparing 6-alkyl-5-arylsulfonyl-dihydrophenanthridines Brian Hugh Ridgway, William J. Moore, William Ronald Solvibile, Amy Tsai-Ting Lee, Molly Hoke +2 more 2008-05-27 $90,544,000
7241791 Substituted 4-(indazol-3-yl)phenols Robert J. Steffan, Edward Matelan, William Ronald Solvibile 2007-07-10 $90,167,000
6605618 Heterocyclic beta-3 adrenergic receptor agonists William Ronald Solvibile, Dominick Anthony Quagliato, Albert J. Molinari 2003-08-12 $248,472,000
6537994 Heterocyclic &bgr;3 adrenergic receptor agonists William Ronald Solvibile 2003-03-25 $184,511,000
6511974 Tricyclic vasopressin agonists John P. Dusza, Peter S. Chan, Jay D. Albright, Jehan F. Bagli, Amedeo A. Failli +3 more 2003-01-28 $282,088,000
6506901 Substituted 2-(S)-hydroxy-3-(piperidin-4-yl-methylamino)-propyl ethers and substituted 2-aryl-2-(R)-hydroxy-1-(piperidin-4-yl-methyl)-ethylamine &bgr;-3 adrenergic receptor agonists Robert J. Steffan, Jeffrey Claude Pelletier, William Ronald Solvibile, Edward Matelan 2003-01-14 $538,292,000
6451814 Heterocyclic &bgr;-3 adrenergic receptor agonists William Ronald Solvibile, Dominick Anthony Quagliato, Albert J. Molinari 2002-09-17 $105,113,000
6297234 Arylthiophene vasopressin agonists Amedeo A. Failli, David K. Williams, Thomas Joseph Caggiano, Jay S. Shumsky 2001-10-02 $712,699,000
6268360 1H-pyrido[2,3-b][1,5]benzodiazipine vasopressin agonists Amedeo A. Failli, David K. Williams, Thomas Joseph Caggiano, Jay S. Shumsky 2001-07-31 $252,954,000
5880122 3-Carboxamide derivatives of 5H-pyrrolo2,1-c!1,4!-benzodiazepines Eugene J. Trybulski, Albert J. Molinari, Jehan F. Bagli, Thomas Joseph Caggiano 1999-03-09 $347,806,000